Xinhua Asia-Pacific news summary at 1600 GMT, Feb. 15

Asia

TOKYO — Japan on Monday reported 965 new daily COVID-19 cases, with the death toll rising by 72 to a total of 7,055 people.

The country’s cumulative total of infection now stands at 418,458, with Tokyo, the hardest hit by the pandemic among Japan’s 47 prefectures, contributing an additional 266 infections on Monday. (Japan-COVID-19)

– – – –

DHAKA — Bangladesh reported 446 new COVID-19 cases and 11 new deaths on Monday, making the tally at 541,038 and death toll at 8,285, the Directorate General of Health Services (DGHS) said.

The official data showed that 14,138 samples were tested in the last 24 hours across Bangladesh.

The total number of recovered patients in the country stood at 487,870 including 641 new recoveries on Monday, said the DGHS. (Bangladesh-COVID-19)

– – – –

COLOMBO — Sri Lankan President Gotabaya Rajapaksa on Monday instructed health authorities to start vaccinating members of the general public in the country’s Western Province with the Oxford Astra Zeneca against the COVID-19 virus.

Officials said they had started vaccinating those who are at high risk of exposure of the virus, such as port workers, private hospital staff members and even garbage collectors who were based in Western Province. (Sri Lanka-COVID19-Vaccination)

– – – –

JAKARTA — The COVID-19 cases in Indonesia rose by 6,462 within one day to 1,223,930, with the death toll adding by 184 to 33,367, the Health Ministry said on Monday.

According to the ministry, 6,792 more people were discharged from hospitals, bringing the total number of recovered patients to 1,032,065. (Indonesia-COVID-19)

– – – –

KUALA LUMPUR — Malaysia reported 2,176 new COVID-19 infections, the health ministry said on Monday, bringing the national total to 266,445.

Health Ministry Director-General Noor Hisham Abdullah said in a press statement that one of the new cases is imported and 2,175 are local transmissions.

Another 10 deaths were reported, pushing the death toll to 975. (Malaysia-COVID-19)

Leave a Reply